Company profile

ASKA Pharmaceutical Holdings CO., Ltd.

EDINET
E35791
Securities
4886
Industry
Pharmaceutical
Industry Peer Ranking
View Company Rankings
Latest annual securities report
2026-06-19 Annual Securities Report PDF HTML
Latest financial report
2026-11-09 Semiannual Securities Report PDF HTML
Latest filing
—

Industry position

Pharmaceutical

View details
Profitability Above average Current Top 33% 5-year trend Broadly stable
Financial strength Average Based on Equity ratio Current Bottom 46% 5-year trend Improving
Growth Above average Current Top 38% 5-year trend Broadly stable
Cash generation Average Current Top 46% 5-year trend Deteriorating

Latest half-year results

H1 FY2027

2026/04/01 - 2026/09/30

Consolidated · Japanese GAAP · Cumulative YTD

For H1 FY2027, revenue was ¥35.63 billion, up 1.1% year over year. Operating income was ¥2.74 billion, up 3.4% year over year. Net income was ¥2.1 billion, down 11.7% year over year.

Revenue ¥35.63B up 1.1% year over year
Operating income ¥2.74B up 3.4% year over year
Net income ¥2.1B down 11.7% year over year
Operating cash flow ¥535M
Free cash flow -¥717M
Total assets ¥111.88B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2026

Consolidated Japanese GAAP

Revenue reached ¥71.13 billion, up 10.9% year over year. Operating income was ¥5.83 billion, up 9.4% year over year. Operating margin was 8.2%. Net income was ¥5.42 billion, up 6.3% year over year. ROE was 7.3%; equity ratio was 62.6%; free cash flow was ¥551 million.

Revenue ¥71.13B up 10.9% year over year
Operating income ¥5.83B up 9.4% year over year
Net income ¥5.42B up 6.3% year over year
Total assets¥112.38B
Total equity—
Operating cash flow¥6.3B
Free cash flow¥551M

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Above average

Operating margin Top 41% / ROE Top 30%

Financial strength Average
Based on Equity ratio

Equity ratio Bottom 56%

Growth Above average

Revenue growth Top 36% / 3-year revenue CAGR Top 47%

Cash generation Average

Operating cash flow margin Top 49% / Free cash flow margin Top 47%

Profitability Industry position history Broadly stable
2026 Top 33% 2025 Top 29% 2024 Top 20% 2023 Top 26% 2022 Top 41%
Financial strength Industry position history Improving
2026 Bottom 46% 2025 Bottom 47% 2024 Bottom 44% 2023 Bottom 34% 2022 Bottom 31%
Growth Industry position history Broadly stable
2026 Top 38% 2025 Bottom 40% 2024 Bottom 48% 2023 Top 44%
Cash generation Industry position history Deteriorating
2026 Top 46% 2025 Top 49% 2024 Top 39% 2023 Top 33% 2022 Top 31%
Profitability Operating margin 8.2% Industry median 6.9% Top 41% Comparison sample 42
Profitability ROE 7.3% Industry median 3.8% Top 30% Comparison sample 48
Financial strength Equity ratio 62.6% Industry median 68.3% Bottom 56% Comparison sample 50
Growth Revenue growth +10.9% Industry median +4.2% Top 36% Comparison sample 31
Growth 3-year revenue CAGR +5.6% Industry median +5.2% Top 47% Comparison sample 26
Cash generation Operating cash flow margin 8.9% Industry median 7.4% Top 49% Comparison sample 43
Cash generation Free cash flow margin 0.8% Industry median -0.6% Top 47% Comparison sample 43

Annual financial data

Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Implied Share Price Implied Market Capitalization Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2026 Consolidated Japanese GAAP 71127000000 5834000000 5665000000 6991000000 5424000000 5424000000 6575000000 112379000000 35559000000 76819000000 63923000000 76819000000 6303000000 -5752000000 -818000000 551000000 10126000000 191.12 12.35 2360.3320 67890699022.0680 2477.81 60.0 28763199 0.6835707739 0.6261 0.0729851379 0.0500538357 0.0820222981 0.0796462665 0.0762579611 0.0886161373 0.0077467066 0.3139388866 0.1089508723 0.0943537798 0.1092617975 0.1290374677 0.0633209175 0.1178208367 0.1101813715 1.5364185111 0.0607446114 0.7232746955 1.151415224 -0.0449872678 0.062072798 0.0909090909 0.0 -0.0128676471 0.0578903234 1611 10213546
FY2025 Consolidated Japanese GAAP 64139000000 5331000000 5107000000 6192000000 5101000000 5101000000 5222000000 100534000000 31339000000 69195000000 60039000000 69195000000 2485000000 -6124000000 -2956000000 -3639000000 10603000000 179.95 12.8 2303.360 66252002048.640 2302.61 55.0 28763199 0.6882746136 0.6496 0.0778036225 0.0507390535 0.0831163567 0.0796239418 0.0795303949 0.0387439779 -0.0567361512 0.3056404557 0.020622822 -0.1798461538 -0.2169579883 -0.3721354695 -0.3239231279 0.1078737121 0.117309866 0.6722745626 -4.5896834701 0.2503170175 -2.140037594 -0.3665312463 -0.3247908146 0.375 -0.0588943585 1.1417322835 -0.0180652298 1632 9654636
FY2024 Consolidated Japanese GAAP 62843000000 6500000000 6522000000 9862000000 7545000000 7545000000 8127000000 90745000000 28815000000 61930000000 56130000000 61930000000 1486000000 1706000000 -3943000000 3192000000 16738000000 266.51 8.33 2220.0283 67851166718.5317 2186.1 40.0 30563199 0.6824618436 0.6825 0.1295690477 0.0831450769 0.1034323632 0.103782442 0.1200611047 0.0236462295 0.0507932467 0.1500881768 0.0393972974 0.272513704 0.246559633 0.8409557588 0.7803209061 0.0413941105 0.1356426384 -0.5565502835 2.5150976909 -1.1664835165 0.4346067416 -0.0438160526 0.7757862473 1.5 0.0 0.0200803213 0.0258148634 762 9832258
FY2023 Consolidated Japanese GAAP 60461000000 5108000000 5232000000 5357000000 4238000000 4238000000 5983000000 87138000000 32604000000 54533000000 49315000000 54533000000 3351000000 -1126000000 -1820000000 2225000000 17505000000 150.08 7.92 1188.6336 36328445254.8864 1928.14 16.0 30563199 0.6258234066 0.6258 0.0819531061 0.0486354977 0.084484213 0.0865351218 0.0700947718 0.0554241577 0.0368005822 0.1066098081 0.0680834526 0.0652763295 0.0721311475 -0.1307804641 -0.0121212121 0.0461121049 0.1153767488 0.1790992259 -1.1669879875 0.3925233645 -0.767866458 0.0235046483 -0.0075386854 0.0666666667 0.0 -0.0386100386 -0.023683612 747 9584827
FY2022 Consolidated Japanese GAAP 56607000000 4795000000 4880000000 6163000000 4290000000 4290000000 4982000000 83297000000 34404000000 48892000000 45419000000 48892000000 2842000000 6743000000 -2996000000 9585000000 17103000000 151.22 8.35 1262.6870 38591754055.7130 1734.8 15.0 30563199 0.5869599145 0.587 0.0515024551 0.0847068384 0.0862084195 0.0757856802 0.0502058049 0.1693253485 0.0991932284 777 9817337

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.